查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球大麻市場：按產品類型（花,濃縮物,可食用,外用/酊劑）,化合物（以THC為主,以CBD為主,THC和CBD平衡）,應用（醫療,娛樂）,地區預測到2027
市場調查報告書
商品編碼
1128174

全球大麻市場：按產品類型（花,濃縮物,可食用,外用/酊劑）,化合物（以THC為主,以CBD為主,THC和CBD平衡）,應用（醫療,娛樂）,地區預測到2027

Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, & Balanced THC & CBD), Application (Medical & Recreational), & Region - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 290 Pages | 訂單完成後即時交付

價格
簡介目錄

預計 2022 年全球大麻市場價值 277 億美元，預計 2027 年將達到 823 億美元，按價值計算的複合年增長率為 24.3%。

大麻市場受到大麻娛樂和醫療用途增加的推動。此外，美國將於 2021 年在弗吉尼亞州、2022 年在羅德島、2021 年在馬耳他和 2018 年在泰國將大麻合法化。

大麻產業正在蓬勃發展，全球增長率達到兩位數。大麻行業擁有幾家大型企業，每個企業都壟斷各自的市場。因此，每家公司都在爭奪較大的市場份額。大麻市場和醫療行業的主要公司正在遵循擴張、投資和收購等無機增長戰略，以增加利潤和市場份額。例如，2020年5月，奧羅拉（Aurora） Cannabis 完成了對美國領先的大麻衍生 CBD 產品營銷商 Reliva LLC （美國）的收購。此次收購是用 4000 萬美元的 Aurora 普通股進行的。此次收購將使公司能夠鞏固其市場地位並提高盈利能力。

“根據應用，預計休閒行業在預測期內將以最高的複合年增長率增長”

在 Z 世代消費者的推動下，對休閒大麻的需求持續增長。由於公眾輿論的變化，一小部分大麻產品面向女性銷售，預計這一比例會隨著時間的推移而增加。大麻合法化也促進了與大麻相關的旅遊業，旅遊目的地生產新穎的度假產品以吸引顧客，並增加了前往大麻合法化目的地的旅遊預訂量。

“按複合計算，THC估計佔據最大份額”

THC 菌株用於醫療和娛樂目的，並且在製造商和消費者中的需求不斷增加。印第安納州生物技術公司Growing Together Research Inc. 宣布了一種新的Delta-9-THC 在大麻中的基因控製表達，包括提高用於娛樂和藥用目的的大麻品種中大麻素水平的能力。開發了這項技術。除了傳統形式，其他形式的 THC，如 delta-8-THC，也越來越受歡迎。

“預計歐洲地區在預測期內將以最高的複合年增長率增長”

歐洲地區的市場受到對該地區大麻的醫療益處的看法以及幾個歐洲國家存在的醫療保健系統的影響，這些醫療保健系統涵蓋了這些地區大多數患者的醫療費用。主要因素。歐洲國家的大麻合法化還處於早期階段，為公司在該地區立足創造了相當大的機會。自 2019 年初以來，歐洲大麻市場出現了多起涉及醫用大麻公司的併購。 2021年醫用大麻公司 GW Pharmaceutical 正被 Jazz Pharmaceutical 以 61.5 億美元收購。

內容

第一章介紹

第二章研究方法

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 宏觀經濟指標
  • 市場動態
    • 驅動程序
    • 限制因素
    • 機會
    • 任務

第 6 章趨勢

  • 簡介
  • 價值鏈
  • 供應鏈分析
  • 影響客戶業務的趨勢/中斷
  • 大麻市場的市場測繪和生態系統
  • 技術分析
  • 價格分析
  • 大麻市場：專利分析
  • 貿易分析：大麻市場
  • 案例研究：大麻市場
  • 2022-2023 年主要會議和活動
  • 監管狀態和監管狀態
  • 波特五力分析
  • 主要利益相關者和採購標準

第 7 章大麻市場：產品類型

  • 簡介
  • 鮮花
  • 專注
  • 可食用
  • 外用酊劑
  • 其他

第 8 章大麻市場：按複合分類

  • 簡介
  • 四氫大麻酚 (THC) - 占主導地位
  • 大麻二酚 (CBD) - 占主導地位
  • 配製的 THC/CBD

第 9 章。大麻市場：按應用分類

  • 簡介
  • 醫療
  • 娛樂

第 10 章大麻市場：按地區劃分

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 意大利
    • 丹麥
    • 荷蘭
    • 法國
    • 其他歐洲
  • 南美洲
    • 智利
    • 哥倫比亞
    • 烏拉圭
    • 其他南美洲
  • 其他地區
    • 以色列
    • 澳大利亞
    • 其他欄目

第 11 章競爭格局

  • 概覽
  • 市場份額分析（2021 年）
  • 主要公司的分部利潤分析
  • 主要公司的戰略
  • 企業評估象限（主要公司）
  • 大麻市場：初創企業/小型企業評級象限（2021 年）
  • 產品發布、交易和其他發展

第 12 章公司簡介

  • 簡介
  • 主要公司
    • CANOPY GROWTH CORPORATION
    • CURALEAF
    • CRESCO LABS
    • GREEN THUMB INDUSTRIES
    • TILRAY
    • TRULIEVE
    • AURORA CANNABIS INC.
    • MEDMEN
    • UNRIVALED BRAND INC.
    • ORGANIGRAM HOLDINGS INC.
    • STENOCARE
    • VIVO CANNABIS INC.
    • TERRASCEND
    • HEXO CORP
    • VILLAGE FARMS INTERNATIONAL INC.
    • VERANO
  • 其他企業（中小企業/新興）
    • THE CRONOS GROUP
    • MEDICAL MARIJUANA, INC.
    • ECOFIBRE LIMITED
    • INDIVA
    • TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.
    • MARICANN GROUP INC
    • SATIPHARM
    • CANNABLISS ORGANIC LLC
    • CONNECTED CANNABIS CO.
    • JUSTICE CANNABIS CO.
    • HENRY'S ORIGINAL

第13章 附錄

簡介目錄
Product Code: FB 6762

The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value. The cannabis market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.

The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share. The leading players in the cannabis market and medical industry are undertaking inorganic growth strategies, such as expansions & investments and acquisitions-to increase their profits and market shares. For instance, in May 2020, Aurora Cannabis Inc. completed the acquisition of Reliva LLC (US), a leader in the sales of hemp-derived CBD products in the US. The acquisition took place for USD 40 million of Aurora's common shares. This acquisition would enable the company to strengthen its position in the market and increase profitability.

"By application, the recreational segment is projected to grow at the highest CAGR during the forecast period."

Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.

"By compound, the THC-dominant segment is estimated to account for the largest share."

THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.

"The Europe region is projected to grow at the highest CAGR during the forecast period"

The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.

Break-up of Primaries:

  • By Value Chain Side: Demand Side-59%, Supply Side-41%
  • By Designation: CXOs-31%, Managers - 24%, D-Level- 30%, and Executives- 45%
  • By Region: Europe - 25%, Asia Pacific - 15%, North America - 45%, RoW - 5%, South America-10%

Leading players profiled in this report:

  • Canopy Growth Corporation (Canada)
  • Aurora Cannabis Inc. (Canada)
  • Medmen Enterprise Inc. (US)
  • Tilray Inc. (US)
  • Unrivaled Brand Inc. (US)
  • VIVO Cannabis Inc. (Canada)
  • The Cronos Group (Canada)
  • Medical Marijuana Inc. (US)
  • Stenocare (Denmark)
  • Trulieve (US)
  • Organigrams Holding Inc. (Canada)
  • Cresco Labs (US)
  • Maricann Group Inc. (Canada)
  • Indiva (Canada)
  • Hexo Corp. (Canada)
  • Ecofibre Limited (Australia)
  • Curaleaf Holdings Inc. (US)
  • Harvest Health and Recreation (US)
  • Green Thumb Industries (US)
  • TerrAscend (Canada)

Research Coverage:

The report segments the cannabis market on the basis on product type, application, compound, and region. In terms of insights, this report has focused on various levels of analyses-the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global cannabis, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:

  • To get a comprehensive overview of the cannabis market
  • To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
  • To gain insights about the major countries/regions in which the cannabis market is flourishing

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • FIGURE 1 MARKET SEGMENTATION
    • 1.3.1 INCLUSIONS AND EXCLUSIONS
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017-2021
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 CANNABIS MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 CANNABIS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)
    • FIGURE 5 CANNABIS MARKET SIZE ESTIMATION (DEMAND-SIDE)
    • 2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • FIGURE 6 CANNABIS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    • FIGURE 7 CANNABIS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION
  • 2.4 ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY

    • TABLE 2 CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 CANNABIS MARKET SIZE, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 2021

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN CANNABIS MARKET
    • FIGURE 13 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET
  • 4.2 CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS
    • FIGURE 14 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 2021
  • 4.3 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND AND COUNTRY
    • FIGURE 15 IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA
  • 4.4 CANNABIS MARKET, BY APPLICATION
    • FIGURE 16 RECREATIONAL SEGMENT TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD
  • 4.5 CANNABIS MARKET, BY COMPOUND
    • FIGURE 17 TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD
  • 4.6 CANNABIS MARKET, BY PRODUCT TYPE AND REGION
    • FIGURE 18 NORTH AMERICA TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INCREASE IN AGING POPULATION
    • FIGURE 19 INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021-2021)
    • 5.2.2 ECONOMIC DOWNTURN
    • FIGURE 20 UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010-2021)
  • 5.3 MARKET DYNAMICS
    • FIGURE 21 CANNABIS MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Rising cannabis demand for medicinal applications
      • 5.3.1.2 Legalization of cannabis and rise in social acceptance
    • FIGURE 22 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2020
      • 5.3.1.3 Growth in R&D activities and technological advancements to be precursors for cannabis business
      • 5.3.1.4 Rising global cannabis sales helping online retailers expand
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Complex regulatory structure for use of cannabis
      • 5.3.2.2 Problems associated with high dose of cannabis consumption
      • 5.3.2.3 Stigmatization of cannabis market
      • 5.3.2.4 Profit margins of manufacturers shrinks as cannabis prices fall
    • FIGURE 23 AVERAGE SELLING PRICES OF CANNABIS, 2019-2022
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Emergence of cannabis legalization in Asia Pacific
      • 5.3.3.2 Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business
      • 5.3.3.3 Inorganic growth strategies adopted by US cannabis companies
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Intensive water consumption and inability to maintain consistency during cannabis cultivation
      • 5.3.4.2 Cannabis-producing businesses face financing difficulties in US
      • 5.3.4.3 Advertising and marketing restrictions in US
      • 5.3.4.4 Supply chain challenges associated with cannabis in US

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN
    • 6.2.1 RESEARCH AND PRODUCT DEVELOPMENT
    • 6.2.2 RAW MATERIAL SOURCING
    • 6.2.3 PRODUCTION
    • 6.2.4 PACKAGING, STORAGE, AND DISTRIBUTION
    • 6.2.5 RETAIL
    • FIGURE 24 CANNABIS MARKET: VALUE CHAIN
  • 6.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 25 CANNABIS MARKET: SUPPLY CHAIN
  • 6.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 6.4.1 REVENUE SHIFT AND NEW REVENUE POCKETS IN CANNABIS MARKET
    • FIGURE 26 REVENUE SHIFT IMPACTING CANNABIS MARKET
  • 6.5 MARKET MAPPING AND ECOSYSTEM OF CANNABIS MARKET
    • 6.5.1 DEMAND-SIDE
    • 6.5.2 SUPPLY-SIDE
    • FIGURE 27 CANNABIS MARKET ECOSYSTEM MAP
    • 6.5.3 ECOSYSTEM MAP
    • TABLE 3 CANNABIS MARKET: ECOSYSTEM
  • 6.6 TECHNOLOGY ANALYSIS
    • 6.6.1 LED GLOW LIGHT
    • 6.6.2 NANOENCAPSULATION
    • 6.6.3 ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN
    • FIGURE 28 PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER
    • 6.6.4 CROP STEERING
    • 6.6.5 VERTICAL FARMING
    • 6.6.6 INNOVATIVE HARDWARE TECH DEVICES
    • 6.6.7 IOT AUTOMATION
    • 6.6.8 GENETIC ENGINEERING
  • 6.7 PRICING ANALYSIS
    • 6.7.1 SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE
    • FIGURE 29 SELLING PRICES OF KEY PLAYERS FOR CANNABIS PRODUCT TYPE
    • TABLE 4 SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE
    • FIGURE 30 AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018-2021 (USD/KG)
    • TABLE 5 FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018-2021 (USD/KG)
    • TABLE 6 CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018-2021 (USD/KG)
    • TABLE 7 EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018-2021 (USD/KG)
    • TABLE 8 TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018-2021 (USD/KG)
    • TABLE 9 OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018-2021 (USD/KG)
  • 6.8 CANNABIS MARKET: PATENT ANALYSIS
    • FIGURE 31 NUMBER OF PATENTS GRANTED FOR CANNABIS MARKET, 2011-2021
    • FIGURE 32 TOP PATENT APPLICANTS FOR CANNABIS MARKET, 2019-2022
    • FIGURE 33 REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS MARKET, 2019-2022
    • 6.8.1 LIST OF MAJOR PATENTS
    • TABLE 10 LIST OF A FEW PATENTS IN CANNABIS MARKET, 2019-2022
  • 6.9 TRADE ANALYSIS: CANNABIS MARKET
    • 6.9.1 EXPORT SCENARIO OF HEMP
    • FIGURE 34 HEMP EXPORT, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 11 EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
    • 6.9.2 IMPORT SCENARIO OF HEMP
    • FIGURE 35 HEMP IMPORT, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 12 IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
  • 6.10 CASE STUDIES: CANNABIS MARKET
    • 6.10.1 FILTER420: ATTEMPTS TO BUILD BRAND VALUE
    • 6.10.2 ONYX AGRONOMICS: PRECISION CANNABIS FACILITY
  • 6.11 KEY CONFERENCES AND EVENTS, 2022-2023
    • TABLE 13 KEY CONFERENCES AND EVENTS IN CANNABIS MARKET
  • 6.12 TARIFF AND REGULATORY LANDSCAPE
    • 6.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.12.2 REGULATORY FRAMEWORK
    • FIGURE 36 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2022
      • 6.12.2.1 North America
    • FIGURE 37 US CANNABIS REGULATORY OVERVIEW, 2022
        • 6.12.2.1.1 US
          • 6.12.2.1.1.1 Alaska-legalization measure approved in November 2014
          • 6.12.2.1.1.2 Arizona-legalization measure approved in November 2020
          • 6.12.2.1.1.3 California-legalization measure approved in November 2016
          • 6.12.2.1.1.4 Colorado-legalization measure approved in November 2012
          • 6.12.2.1.1.5 Connecticut-legalization measure approved in June 2021
          • 6.12.2.1.1.6 Guam-legalization measure approved in April 2019
          • 6.12.2.1.1.7 Illinois-legalization measure approved in May 2019
          • 6.12.2.1.1.8 Maine-legalization measure approved in November 2016
          • 6.12.2.1.1.9 Massachusetts-legalization measure approved in November 2016
          • 6.12.2.1.1.10 Michigan-legalization measure approved in November 2018
          • 6.12.2.1.1.11 Montana-legalization measure approved in January 2021
          • 6.12.2.1.1.12 New Jersey-legalization measure approved in November 2020
          • 6.12.2.1.1.13 New Mexico- legalization measure approved in April 2021
          • 6.12.2.1.1.14 New York-legalization measure approved in March 2021
          • 6.12.2.1.1.15 Oregon-legalization measure approved in November 2014
          • 6.12.2.1.1.16 Rhode Island-legalization measure approved in May 2022
          • 6.12.2.1.1.17 Vermont-legalization measure approved in January 2018
          • 6.12.2.1.1.18 Virginia-legalization measure approved in April 2021
          • 6.12.2.1.1.19 Washington-legalization measure approved in November 2012
        • 6.12.2.1.2 Canada
      • 6.12.2.2 Europe
        • 6.12.2.2.1 German-legalization measure approved in 2017
        • 6.12.2.2.2 Italy-legalization measure approved in 2014
        • 6.12.2.2.3 Denmark-legalization measure approved in January 2018
        • 6.12.2.2.4 Malta-legalization measure approved in January 2018
        • 6.12.2.2.5 Netherlands-legalization measure approved in January 2013
        • 6.12.2.2.6 France-legalization measure approved in March 2022
        • 6.12.2.2.7 Switzerland
        • 6.12.2.2.8 UK
        • 6.12.2.2.9 Belgium
        • 6.12.2.2.10 Poland
        • 6.12.2.2.11 Czech Republic
        • 6.12.2.2.12 Spain
        • 6.12.2.2.13 Austria
        • 6.12.2.2.14 Norway
        • 6.12.2.2.15 Finland
        • 6.12.2.2.16 Croatia
      • 6.12.2.3 South America
        • 6.12.2.3.1 Chile-legalization measure approved in 2015
        • 6.12.2.3.2 Colombia-legalization measure approved in 2015
        • 6.12.2.3.3 Uruguay-legalization measure approved in December 2013
      • 6.12.2.4 Rest of the world
        • 6.12.2.4.1 Israel-legalization measure approved in December 2018
        • 6.12.2.4.2 Australia-legalization measure approved in February 2016
        • 6.12.2.4.3 Thailand
        • 6.12.2.4.4 South Korea
        • 6.12.2.4.5 Malaysia
        • 6.12.2.4.6 South Africa
  • 6.13 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 18 CANNABIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.13.1 DEGREE OF COMPETITION
    • 6.13.2 BARGAINING POWER OF SUPPLIERS
    • 6.13.3 BARGAINING POWER OF BUYERS
    • 6.13.4 THREAT OF SUBSTITUTES
    • 6.13.5 THREAT OF NEW ENTRANTS
  • 6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 38 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS
    • TABLE 19 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%)
    • 6.14.2 BUYING CRITERIA
    • FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
    • TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR

7 CANNABIS MARKET, BY PRODUCT TYPE

  • 7.1 INTRODUCTION
    • FIGURE 40 CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027
    • TABLE 21 CANNABIS MARKET, BY PRODUCT TYPE, 2018-2021 (USD MILLION)
    • TABLE 22 CANNABIS MARKET, BY PRODUCT TYPE, 2022-2027 (USD MILLION)
    • TABLE 23 CANNABIS MARKET, BY PRODUCT TYPE, 2018-2021 (TONS)
    • TABLE 24 CANNABIS MARKET, BY PRODUCT TYPE, 2022-2027 (TONS)
  • 7.2 FLOWERS
    • 7.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN
    • TABLE 25 FLOWERS: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 26 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 27 FLOWERS: CANNABIS MARKET, BY REGION, 2018-2021 (TONS)
    • TABLE 28 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)
  • 7.3 CONCENTRATES
    • 7.3.1 VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET
    • TABLE 29 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 30 CONCENTRATES: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 31 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018-2021 (TONS)
    • TABLE 32 CONCENTRATES: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)
  • 7.4 EDIBLES
    • 7.4.1 FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES
    • TABLE 33 EDIBLES: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 34 EDIBLES: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 35 EDIBLES: CANNABIS MARKET, BY REGION, 2018-2021 (TONS)
    • TABLE 36 EDIBLES: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)
  • 7.5 TOPICALS & TINCTURES
    • 7.5.1 TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY
    • TABLE 37 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 38 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 39 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018-2021 (TONS)
    • TABLE 40 TOPICALS & TINCTURES: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)
  • 7.6 OTHER PRODUCT TYPES
    • TABLE 41 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 42 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 43 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018-2021 (TONS)
    • TABLE 44 OTHER PRODUCT TYPES: CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)

8 CANNABIS MARKET, BY COMPOUND

  • 8.1 INTRODUCTION
    • FIGURE 41 CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027
    • TABLE 45 CANNABIS MARKET, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 46 CANNABIS MARKET, BY COMPOUND, 2022-2027 (USD MILLION)
  • 8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT
    • 8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET
    • TABLE 47 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 48 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 8.3 CANNABIDIOL (CBD)-DOMINANT
    • 8.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET
    • TABLE 49 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 50 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 8.4 BALANCED THC & CBD
    • 8.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC
    • TABLE 51 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 52 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)

9 CANNABIS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 42 CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027
    • TABLE 53 CANNABIS MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
    • TABLE 54 CANNABIS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
  • 9.2 MEDICAL
    • 9.2.1 INCREASE IN CANNABIS USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS
      • 9.2.1.1 Pain management
      • 9.2.1.2 Neurological health management
      • 9.2.1.3 Mental health management
      • 9.2.1.4 Other medical applications
    • TABLE 55 MEDICAL: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 56 MEDICAL: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 9.3 RECREATIONAL
    • 9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH
    • TABLE 57 RECREATIONAL: CANNABIS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 58 RECREATIONAL: CANNABIS MARKET, BY REGION, 2022-2027 (USD MILLION)

10 CANNABIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 43 REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022-2027
    • TABLE 59 CANNABIS MARKET SIZE, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 60 CANNABIS MARKET SIZE, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 61 CANNABIS MARKET SIZE, BY REGION, 2018-2021 (TONS)
    • TABLE 62 CANNABIS MARKET SIZE, BY REGION, 2022-2027 (TONS)
  • 10.2 NORTH AMERICA
    • FIGURE 44 NORTH AMERICA: CANNABIS MARKET SNAPSHOT
    • TABLE 63 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018-2021 (USD MILLION)
    • TABLE 64 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 65 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION)
    • TABLE 66 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 67 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 68 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • TABLE 69 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (USD MILLION)
    • TABLE 70 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (USD MILLION)
    • TABLE 71 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (TONS)
    • TABLE 72 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (TONS)
    • 10.2.1 US
      • 10.2.1.1 Increase in mergers, investments, and sales drive cannabis market in US
    • TABLE 73 US: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 74 US: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Presence of major players in Canada boosts growth during forecast period
    • TABLE 75 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 76 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.2.3 MEXICO
      • 10.2.3.1 Medical cannabis used for epilepsy treatment boosts Mexican cannabis market growth
    • TABLE 77 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 78 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
  • 10.3 EUROPE
    • FIGURE 45 EUROPE: CANNABIS MARKET SNAPSHOT
    • TABLE 79 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018-2021 (USD MILLION)
    • TABLE 80 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 81 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION)
    • TABLE 82 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 83 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 84 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • TABLE 85 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (USD MILLION)
    • TABLE 86 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (USD MILLION)
    • TABLE 87 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (TONS)
    • TABLE 88 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (TONS)
    • 10.3.1 GERMANY
      • 10.3.1.1 Health insurance coverage for cannabis use in medical treatments driving market
    • TABLE 89 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 90 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.3.2 ITALY
      • 10.3.2.1 Increase in demand for cannabis and issuance of import licenses to drive market
    • TABLE 91 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 92 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.3.3 DENMARK
      • 10.3.3.1 Huge demand for medical cannabis to drive Danish medical cannabis market
    • TABLE 93 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 94 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.3.4 NETHERLANDS
      • 10.3.4.1 Strong infrastructure and rise in export of medical cannabis to other countries drive market
    • TABLE 95 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 96 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.3.5 FRANCE
      • 10.3.5.1 Government providing finance to healthcare systems and refunds provided to patients
    • TABLE 97 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 98 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 99 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 100 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
  • 10.4 SOUTH AMERICA
    • TABLE 101 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018-2021 (USD MILLION)
    • TABLE 102 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 103 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION)
    • TABLE 104 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 105 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 106 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • TABLE 107 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (USD MILLION)
    • TABLE 108 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (USD MILLION)
    • TABLE 109 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (TONS)
    • TABLE 110 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (TONS)
    • 10.4.1 CHILE
      • 10.4.1.1 Rise in consumption of cannabis for medical usage driving market
    • TABLE 111 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 112 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.4.2 COLOMBIA
      • 10.4.2.1 Increased cannabis license distribution to companies drives market
    • TABLE 113 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 114 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.4.3 URUGUAY
      • 10.4.3.1 Fully legalized cannabis industry with eased regulations drives market
    • TABLE 115 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 116 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.4.4 REST OF SOUTH AMERICA
    • TABLE 117 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 118 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
  • 10.5 ROW
    • TABLE 119 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018-2021 (USD MILLION)
    • TABLE 120 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 121 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION)
    • TABLE 122 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 123 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 124 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • TABLE 125 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (USD MILLION)
    • TABLE 126 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (USD MILLION)
    • TABLE 127 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018-2021 (TONS)
    • TABLE 128 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022-2027 (TONS)
    • 10.5.1 ISRAEL
      • 10.5.1.1 Technical innovations and increased exports to drive market
    • TABLE 129 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 130 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.5.2 AUSTRALIA
      • 10.5.2.1 Surge in epilepsy, chronic pain, and cancer patients resulted in market growth
    • TABLE 131 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 132 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)
    • 10.5.3 OTHERS IN ROW
    • TABLE 133 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018-2021 (USD MILLION)
    • TABLE 134 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS, 2021
    • TABLE 135 CANNABIS MARKET: DEGREE OF COMPETITION (FRAGMENTED)
  • 11.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
    • FIGURE 46 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017-2021 (USD MILLION)
  • 11.4 KEY PLAYER STRATEGIES
    • TABLE 136 STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS
  • 11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 47 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
    • 11.5.5 PRODUCT FOOTPRINT
    • TABLE 137 COMPANY FOOTPRINT, BY APPLICATION
    • TABLE 138 COMPANY FOOTPRINT, BY TYPE
    • TABLE 139 COMPANY FOOTPRINT, BY REGION
    • TABLE 140 OVERALL COMPANY FOOTPRINT
  • 11.6 CANNABIS MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 48 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES)
    • 11.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
    • TABLE 141 CANNABIS MARKET: DETAILED LIST OF KEY STARTUP/SMES
    • TABLE 142 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
    • 11.7.1 PRODUCT LAUNCHES
    • TABLE 143 CANNABIS: PRODUCT LAUNCHES, 2019-2022
    • 11.7.2 DEALS
    • TABLE 144 CANNABIS: DEALS, 2019-2022
    • 11.7.3 OTHERS
    • TABLE 145 CANNABIS: OTHERS, 2019-2022

12 COMPANY PROFILES

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER
  • (Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)**
    • 12.2.1 CANOPY GROWTH CORPORATION
    • TABLE 146 CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW
    • FIGURE 49 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
    • TABLE 147 CANOPY GROWTH CORPORATION: PRODUCTS OFFERED
    • TABLE 148 CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES
    • TABLE 149 CANOPY GROWTH CORPORATION: DEALS
    • TABLE 150 CANOPY GROWTH CORPORATION: OTHERS
    • 12.2.2 CURALEAF
    • TABLE 151 CURALEAF: BUSINESS OVERVIEW
    • FIGURE 50 CURALEAF: COMPANY SNAPSHOT
    • TABLE 152 CURALEAF: PRODUCTS OFFERED
    • TABLE 153 CURALEAF: NEW PRODUCT LAUNCHES
    • TABLE 154 CURALEAF: DEALS
    • TABLE 155 CURALEAF: OTHERS
    • 12.2.3 CRESCO LABS
    • TABLE 156 CRESCO LABS: BUSINESS OVERVIEW
    • FIGURE 51 CRESCO LABS: COMPANY SNAPSHOT
    • TABLE 157 CRESCO LABS: PRODUCTS OFFERED
    • TABLE 158 CRESCO LABS: NEW PRODUCT LAUNCHES
    • TABLE 159 CRESCO LABS: DEALS
    • TABLE 160 CRESCO LABS: OTHERS
    • 12.2.4 GREEN THUMB INDUSTRIES
    • TABLE 161 GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW
    • FIGURE 52 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT
    • TABLE 162 GREEN THUMB INDUSTRIES: PRODUCTS OFFERED
    • TABLE 163 GREEN THUMB INDUSTRIES: DEALS
    • TABLE 164 GREEN THUMB INDUSTRIES: OTHERS
    • 12.2.5 TILRAY
    • TABLE 165 TILRAY: BUSINESS OVERVIEW
    • FIGURE 53 TILRAY: COMPANY SNAPSHOT
    • TABLE 166 TILRAY INC: PRODUCTS OFFERED
    • TABLE 167 TILRAY: NEW PRODUCT LAUNCHES
    • TABLE 168 TILRAY: DEALS
    • TABLE 169 TILRAY: OTHERS
    • 12.2.6 TRULIEVE
    • TABLE 170 TRULIEVE: BUSINESS OVERVIEW
    • FIGURE 54 TRULIEVE: COMPANY SNAPSHOT
    • TABLE 171 TRULIEVE: PRODUCTS OFFERED
    • TABLE 172 TRULIEVE: DEALS
    • TABLE 173 TRULIEVE: OTHERS
    • 12.2.7 AURORA CANNABIS INC.
    • TABLE 174 AURORA CANNABIS INC.: BUSINESS OVERVIEW
    • FIGURE 55 AURORA CANNABIS INC.: COMPANY SNAPSHOT
    • TABLE 175 AURORA CANNABIS INC.: PRODUCTS OFFERED
    • TABLE 176 AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES
    • TABLE 177 AURORA CANNABIS INC.: DEALS
    • TABLE 178 AURORA CANNABIS INC.: OTHERS
    • 12.2.8 MEDMEN
    • TABLE 179 MEDMEN: BUSINESS OVERVIEW
    • FIGURE 56 MEDMEN: COMPANY SNAPSHOT
    • TABLE 180 MEDMEN: PRODUCTS OFFERED
    • TABLE 181 MEDMEN: OTHERS
    • 12.2.9 UNRIVALED BRAND INC.
    • TABLE 182 UNRIVALED BRAND INC.: BUSINESS OVERVIEW
    • FIGURE 57 UNRIVALED BRAND INC.: COMPANY SNAPSHOT
    • TABLE 183 UNRIVALED BRAND INC.: PRODUCTS OFFERED
    • TABLE 184 UNRIVALED BRAND INC.: DEALS
    • TABLE 185 UNRIVALED BRAND INC.: OTHERS
    • 12.2.10 ORGANIGRAM HOLDINGS INC.
    • TABLE 186 ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW
    • FIGURE 58 ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT
    • TABLE 187 ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED
    • TABLE 188 ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH
    • TABLE 189 ORGANIGRAM HOLDINGS INC.: DEALS
    • TABLE 190 ORGANIGRAM HOLDINGS INC.: OTHERS
    • 12.2.11 STENOCARE
    • TABLE 191 STENOCARE: BUSINESS OVERVIEW
    • FIGURE 59 STENOCARE: COMPANY SNAPSHOT
    • TABLE 192 STENOCARE: PRODUCTS OFFERED
    • TABLE 193 STENOCARE: DEALS
    • TABLE 194 STENOCARE: OTHERS
    • 12.2.12 VIVO CANNABIS INC.
    • TABLE 195 VIVO CANNABIS INC.: BUSINESS OVERVIEW
    • FIGURE 60 VIVO CANNABIS INC.: COMPANY SNAPSHOT
    • TABLE 196 VIVO CANNABIS INC.: PRODUCTS OFFERED
    • TABLE 197 VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES
    • TABLE 198 VIVO CANNABIS INC.: DEALS
    • TABLE 199 VIVO CANNABIS INC.: OTHERS
    • 12.2.13 TERRASCEND
    • TABLE 200 TERRASCEND: BUSINESS OVERVIEW
    • FIGURE 61 TERRASCEND: COMPANY SNAPSHOT
    • TABLE 201 TERRASCEND: PRODUCTS OFFERED
    • TABLE 202 TERRASCEND: DEALS
    • TABLE 203 TERRASCEND: OTHERS
    • 12.2.14 HEXO CORP
    • TABLE 204 HEXO CORP: BUSINESS OVERVIEW
    • FIGURE 62 HEXO CORP: COMPANY SNAPSHOT
    • TABLE 205 HEXO CORP: PRODUCTS OFFERED
    • TABLE 206 HEXO CORP: NEW PRODUCT LAUNCHES
    • TABLE 207 HEXO CORP: DEALS
    • TABLE 208 HEXO CORP: OTHERS
    • 12.2.15 VILLAGE FARMS INTERNATIONAL INC.
    • TABLE 209 VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW
    • FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT
    • TABLE 210 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED
    • TABLE 211 VILLAGE FARMS INTERNATIONAL INC.: OTHERS
    • 12.2.16 VERANO
    • TABLE 212 VERANO: BUSINESS OVERVIEW
    • FIGURE 64 VERANO: COMPANY SNAPSHOT
    • TABLE 213 VERANO: PRODUCTS OFFERED
    • TABLE 214 VERANO: DEALS
    • TABLE 215 VERANO: OTHERS
  • 12.3 OTHER PLAYERS (SMES/STARTUPS)
    • 12.3.1 THE CRONOS GROUP
    • TABLE 216 THE CRONOS GROUP: BUSINESS OVERVIEW
    • FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT
    • TABLE 217 THE CRONOS GROUP: PRODUCTS OFFERED
    • TABLE 218 THE CRONOS GROUP: DEALS
    • TABLE 219 THE CRONOS GROUP: OTHERS
    • 12.3.2 MEDICAL MARIJUANA, INC.
    • TABLE 220 MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW
    • FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
    • TABLE 221 MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED
    • TABLE 222 MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES
    • TABLE 223 MEDICAL MARIJUANA, INC.: DEALS
    • TABLE 224 MEDICAL MARIJUANA, INC.: OTHERS
    • 12.3.3 ECOFIBRE LIMITED
    • TABLE 225 ECOFIBRE LIMITED: BUSINESS OVERVIEW
    • FIGURE 67 ECOFIBRE LIMITED: COMPANY SNAPSHOT
    • TABLE 226 ECOFIBRE LIMITED: PRODUCTS OFFERED
    • TABLE 227 ECOFIBRE LIMITED: OTHERS
    • 12.3.4 INDIVA
    • TABLE 228 INDIVA: BUSINESS OVERVIEW
    • FIGURE 68 INDIVA: COMPANY SNAPSHOT
    • TABLE 229 INDIVA: PRODUCTS OFFERED
    • TABLE 230 INDIVA: NEW PRODUCT LAUNCHES
    • TABLE 231 INDIVA: DEALS
    • TABLE 232 INDIVA: OTHERS
    • 12.3.5 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.
    • TABLE 233 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW
    • TABLE 234 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED
    • 12.3.6 MARICANN GROUP INC
    • TABLE 235 MARICANN GROUP INC: BUSINESS OVERVIEW
    • TABLE 236 MARICANN GROUP INC: PRODUCTS OFFERED
    • 12.3.7 SATIPHARM
    • 12.3.8 CANNABLISS ORGANIC LLC
    • 12.3.9 CONNECTED CANNABIS CO.
    • 12.3.10 JUSTICE CANNABIS CO.
    • 12.3.11 HENRY'S ORIGINAL
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATIONS OFFERED
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS